SCYNEXIS, Inc. Share Price
SCYXSCYNEXIS, Inc. Stock Performance
Open $4.20 | Prev. Close $4.32 | Circuit Range N/A |
Day Range $4.17 - $4.29 | Year Range $0.57 - $5.49 | Volume 1,502 |
Average Traded $4.21 |
SCYNEXIS, Inc. Share Price Chart
About SCYNEXIS, Inc.
SCYNEXIS, Inc., a biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States. It offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, a drug for the treatment of invasive candidiasis and/or candidemia, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It also develops SCY-247 to treat systemic fungal diseases. The company has licensing and collaboration agreements with GlaxoSmithKline Intellectual Property (No. 3) Limited, Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, CJSC (R-Pharm), and Cypralis Limited for the development, manufacture, and commercialization of ibrexafungerp. SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. The company was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
SCYNEXIS, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
10-Jun-26 | $4.20 | $4.20 | +0.00% |
10-Jun-26 | $4.20 | $4.20 | -2.78% |
09-Jun-26 | $4.42 | $4.32 | -3.36% |
08-Jun-26 | $4.70 | $4.47 | -4.89% |
05-Jun-26 | $4.88 | $4.70 | -2.89% |
04-Jun-26 | $4.96 | $4.84 | +3.64% |
03-Jun-26 | $4.91 | $4.67 | -8.43% |
FAQs on SCYNEXIS, Inc. Share Price
Can I buy SCYNEXIS, Inc. shares in India?
What is the share price of SCYNEXIS, Inc.?
What is the 5 year returns of SCYNEXIS, Inc.?
What are the high & low stock price of SCYNEXIS, Inc. today?
What is the 52-week high and low of SCYNEXIS, Inc. stock?